SMI
|
15 106,12
|
-43,31
|
-0,29 %
|
Analysen zu SMI-Werten
| 13.11.26 | Richemont Buy | Deutsche Bank AG | |
| 13.11.26 | Richemont Buy | Jefferies & Company Inc. | |
| 13.11.26 | Richemont Outperform | Bernstein Research | |
| 13.11.26 | Richemont Outperform | RBC Capital Markets | |
| 12.11.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 12.11.26 | Zurich Insurance Outperform | RBC Capital Markets | |
| 11.11.26 | Novartis Hold | Jefferies & Company Inc. | |
| 11.11.26 | Givaudan Hold | Jefferies & Company Inc. | |
| 11.11.26 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.11.26 | Swiss Re Halten | DZ BANK | |
| 10.11.26 | Novartis Sell | Deutsche Bank AG | |
| 10.11.26 | Nestlé Market-Perform | Bernstein Research | |
| 09.11.26 | Novartis Hold | Jefferies & Company Inc. | |
| 06.11.26 | Swiss Re Underperform | Jefferies & Company Inc. | |
| 06.11.26 | Swiss Re Underweight | Barclays Capital | |
| 06.11.26 | Swiss Re Sell | UBS AG | |
| 06.11.26 | UBS Outperform | RBC Capital Markets | |
| 05.11.26 | Swiss Re Underperform | RBC Capital Markets | |
| 05.11.26 | Swiss Re Underperform | Jefferies & Company Inc. | |
| 05.11.26 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 04.11.26 | ABB Neutral | UBS AG | |
| 04.11.26 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.11.26 | Roche Neutral | UBS AG | |
| 02.11.26 | Novartis Sell | Deutsche Bank AG | |
| 30.10.26 | UBS Kaufen | DZ BANK | |
| 30.10.26 | ABB Neutral | Goldman Sachs Group Inc. | |
| 29.10.26 | Novartis Market-Perform | Bernstein Research | |
| 29.10.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 28.10.26 | Novartis Neutral | UBS AG | |
| 28.10.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 28.10.26 | Roche Buy | Deutsche Bank AG | |
| 28.10.26 | Novartis Hold | Deutsche Bank AG | |
| 28.10.26 | UBS Outperform | RBC Capital Markets | |
| 28.10.26 | Novartis Sector Perform | RBC Capital Markets | |
| 27.10.26 | Novartis Hold | Deutsche Bank AG | |
| 27.10.26 | Novartis Hold | Jefferies & Company Inc. | |
| 27.10.26 | Novartis Market-Perform | Bernstein Research | |
| 27.10.26 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 26.10.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 26.10.26 | Novartis Neutral | UBS AG |